Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of culturing cells in suspension
Patent
1995-06-07
1998-09-08
Hutzell, Paula K.
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of culturing cells in suspension
435 2, 4352402, 43524021, 43524025, 435325, 435366, 435372, 435384, 435392, C12N 500, C12N 502
Patent
active
058044469
ABSTRACT:
The present invention relates to a population of blood borne mammalian cells that express a unique profile of surface markers that includes certain markers typical of connective tissue fibroblasts, and are referred to herein as "blood-borne mesenchymal cells." In particular, it relates to the isolation, characterization and uses of such blood-borne mesenchymal cells. The cells of the present invention can be distinguished from peripheral blood leukocytes by their distinct size, morphology, cell surface phenotype and biologic activities, and are likewise distinguishable from connective tissue fibroblasts by other surface phenotypic markers. These cells proliferate in culture, and in vivo, as demonstrated in animal models, are capable of migrating into wound sites from the blood. Therefore, such blood-borne mesenchymal cells may have a wide range of applications, including, but not limited to, the promotion of wound healing, tissue remodeling, and for gene therapy.
REFERENCES:
patent: 5197985 (1993-03-01), Caplan et al.
patent: 5226914 (1993-07-01), Caplan et al.
patent: 5654186 (1997-08-01), Cerami et al.
Bucala et al Molecular Medicine (1994) 1 (1) pp. 71-81.
Sekhsaria et al Blood (1993) 81 (8) pp. 2125-2130. Abstract Only.
Van Epps et al Blood Cells (1994) 20 (2-3) pp. 411-423 Abstract Only.
Bender et al Blood (1991) 77(12) 2591--2596.
Roitt et al (eds) "Immunology, Third Edition" Mosby Press p. 1.13, 1993.
Lang et al Growth Factors 1992 6(2) pp. 131-138, Abstract "TNF alpha, IL-I alpha and bFGF are implicated in the complex disease of GM-CSF transgenic mice", 1992.
Honegger et al Pharmacol Toxicol 73(4) pp. 202-208, Abstract "Evidence for Lysosomotropism of memantine in cultured human cells", 1993.
Altmannsberger, Veroff Pathol 127 pp. 1-105, Abstract "Intermediate Filaments Proteins as Markers in Tumour Diagnosis", 1988.
Cole et al Am. J. Anat. 180(3) pp. 237-242, Abstract, Nov. 1987.
Kinsella et al Arthritis Rheum., May 1989 32(5) pp. 577-583 Abstract.
Heinden kummer et al Graefes Arch Clin Exp Opthalmol 229(5) pp. 492-496, Abstract, 1991.
Certified English translation of Voskresenkii et al. (1988) Ontogenesis (19):247-52.
Caplan, A.I. (1990) Biomat 11:89.
Haynesworth et al. (1992) Bone 13:69-80.
Haynesworth et al. (1992) Bone 13:81-88.
Nakahara et al. (1990) Bone 11:181-8.
Nakahara et al. (1991) Experimental Cell Res. 195:492-503.
Bucala et al. (1993) The FASEB J. 7:A139.
Andreoni et al. (1990) Exp. Hematol. 18:431.
Allgower, M. (1956) In: The Cellular Basis of Wound Repair, Charles C. Thomas Publisher, Springfield, Illinois, USA,. pp. 44-50 and 108.
Allgower, M. (1963) Proceedings of a Workshop, The Committee on T, National Academy of Science--National Research Council, 5-8, Dec., pp. 160-164.
Allgower, M. (1974) Cellular Basis of Wound Repair, International Symposium on Wound Healing, Rotterdam, pp. 16-20.
Bucala Richard J.
Cerami Anthony
Bakalyar Heather A.
Hutzell Paula K.
Oster Jeffrey B.
The Picower Institute for Medical Research
LandOfFree
Blood-borne mesenchymal cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Blood-borne mesenchymal cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood-borne mesenchymal cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281353